Mavengity Expands into B2B Research
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the Article8th Circuit ruling
3 storiesS-1 public filing
1 storyTrump-Xi summit Sep 24
2 storiesJoint proposed final judgment Oct 2
1 storyNon-renewal notice deadline Oct 2
2 storiesFirst exempt-venue token listings Oct 17
Senate Bill 319 takes effect January 1 and requires Utah insurers to disclose AI use and to base adverse determinations on independent medical judgment rather than a recommendation from any other source.
Michigan removed gabapentin from its controlled substance schedule in May 2024, and Medicaid dispensing rose right away, a rare read on what a scheduling decision does to prescribing.
The US embassy in Canberra used Australia's consultation on a digital duty of care to argue that mandating how platforms rank content is viewpoint-based censorship. Australia's prime minister answered that the law hands choice back to users, and the bill still goes to parliament this year.
Britain's prime minister told the UN the UK would use its G20 presidency to agree a single set of global AI principles. Hours earlier, the US president rejected any globalist scheme to control the technology and said he wants it renamed super intelligence.
Viking's maintenance study found that stretching VK2735 dosing to every other week or monthly preserved most of the weight loss over 12 weeks, with gastrointestinal side effects no worse than placebo. The weight endpoints were exploratory.
Celldex's barzolvolimab met the primary endpoint and every key secondary in two Phase 3 hives trials, then the shares fell as two anaphylaxis cases moved to the center of the filing question.
Federal credit unions joined the list of institutions exempt from Illinois's interchange fee ban, leaving a coverage map drawn by charter type and a July 2027 deadline for the institutions still inside it.
The complaint names three manufacturers, three pharmacy benefit managers and the aggregators that negotiate and retain fees on their behalf, arriving after the FTC already settled with two of the three PBM families.
The new rule codifies a permanent authority to suspend agent and broker registration, then uses it for the first time on the brokers who joined last year while 315,000 enrollments covering 760,000 people come off the books.
Non-English intent signal is still under twenty percent of total volume industrywide, which means most platforms are seeing a fraction of the buying activity happening outside English language markets.
One vendor is explicitly competing on restraint, arguing that a plausible AI generated article that is subtly wrong is worse for a knowledge base than no article at all.
Forrester's own buyer guidance undercuts the AI pitch: providers are getting measurably more efficient, and there is little evidence yet that any of that efficiency is reaching customer pricing.
Forrester's guidance to buyers is blunt: having a data centre in the EU answers one sovereignty question out of four, and most vendor pitches stop at the first.
Forrester frames 2026's binding constraint as a workforce that cannot be trained fast enough, which makes this a services category built around people more than platforms.
Generative AI should have commoditized this category, and instead Forrester's criteria count kept climbing, because the moat was always licensed source access, not summarization.
Two of the category's most prominent independent players are now owned by the card networks they were supposed to route around.
Forrester's provider count nearly doubled in three years, and every other technology category in this series points at the same root cause: the software works and the organisation does not change.
Every reference customer for one vendor said they would buy again, which in PLM can mean genuine excellence or a customer base that has nowhere else to go once the evidence chain is built.
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the ArticleWith James now writing full time for our Healthcare & Medical desk, Mavengity has formally expanded into dedicated medical authorship.
Read the Article